Literature DB >> 1618698

Progression of weakly malignant clone cells derived from rat mammary carcinoma by host cells reactive to plastic plates.

J Hamada1, N Takeichi, F Okada, J Ren, X Li, M Hosokawa, H Kobayashi.   

Abstract

Tumor progression is the process by which tumor cells acquire more malignant properties, such as invasiveness and metastasis, during tumor development. To elucidate mechanisms of tumor progression, we examined the role of interactions between the tumor and its host by using a cloned cell line, ER-1, which was derived from a rat mammary carcinoma. ER-1 is weakly tumorigenic and non-metastatic when s.c. injected into syngeneic hosts in single cell suspension. However, ER-1 cells show a high incidence of lethal growth when s.c. implanted (5 x 10(2) cells), being attached to a 10 x 5 x 1 mm polystyrene plate. Tumor cell lines (PLT) obtained from tumors which had arisen from the plate-attached ER-1 cells no longer required plates for their growth in normal hosts, and had acquired metastatic ability to the lungs. The malignant phenotypes of PLT were stable under a usual culture condition for at least 6 months. Furthermore, the incidence of tumor development increased when small numbers of ER-1 cells were injected onto plates (or at their periphery) which had previously been implanted s.c. without tumor cells. The tumorigenicity of ER-1 cells increased after they were cocultivated for more than 30 days with host reactive cells obtained from the tissues surrounding the plates. These results suggest that host cells reactive to the foreign body (plastic plate) may not only promote the local growth of ER-1 cells but also convert them into much more malignant tumors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1618698      PMCID: PMC5918850          DOI: 10.1111/j.1349-7006.1992.tb01953.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


a rat mammary carcinoma a weakly tumorigenic and non‐metastatic cell line derived from c‐SST‐2 a tumor cell line derived from the plate‐attached ER‐1 cells 6‐thioguanine ouabain ethyl methanesulfonate Dulbecco's modified medium newborn calf serum phosphate‐buffered saline.
  29 in total

1.  Macrophage potentiation of invasive capacity of rat ascites hepatoma cells.

Authors:  M Mukai; K Shinkai; R Tateishi; Y Mori; H Akedo
Journal:  Cancer Res       Date:  1987-04-15       Impact factor: 12.701

2.  Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta.

Authors:  T A Mustoe; G F Pierce; A Thomason; P Gramates; M B Sporn; T F Deuel
Journal:  Science       Date:  1987-09-11       Impact factor: 47.728

3.  Macrophage-mediated induction of drug-resistant variants in a mouse mammary tumor cell line.

Authors:  K Yamashina; B E Miller; G H Heppner
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701

Review 4.  Interleukin 1: an immunological perspective.

Authors:  S K Durum; J A Schmidt; J J Oppenheim
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

Review 5.  Mechanisms of tumor progression.

Authors:  P C Nowell
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701

Review 6.  Some effects of mechanical trauma on the development of primary cancers and their metastases.

Authors:  L Weiss
Journal:  J Forensic Sci       Date:  1990-05       Impact factor: 1.832

7.  Malignant hemangioendotheliomas produced by subcutaneous inoculation of Balb/3T3 cells attached to glass beads.

Authors:  C W Boone
Journal:  Science       Date:  1975-04-04       Impact factor: 47.728

8.  Macrophage-mediated tumor cell killing: regulation of expression of cytolytic activity by prostaglandin E.

Authors:  S M Taffet; S W Russell
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

9.  Phagocytes as carcinogens: malignant transformation produced by human neutrophils.

Authors:  S A Weitzman; A B Weitberg; E P Clark; T P Stossel
Journal:  Science       Date:  1985-03-08       Impact factor: 47.728

10.  Tumorigenicity of sarcoma cells is enhanced by the local environment of implanted foreign body.

Authors:  T G Moizhess
Journal:  Int J Cancer       Date:  1982-10-15       Impact factor: 7.396

View more
  3 in total

1.  Characterization of the progressive sublines derived from a weakly malignant cloned cell line, ER-1, co-inoculated subcutaneously with a foreign body.

Authors:  J Hamada; H Nagayasu; T Kawano; T Mizutani; D Nakata; M Hosokawa; N Takeichi
Journal:  Clin Exp Metastasis       Date:  1998-04       Impact factor: 5.150

2.  Progression of a weakly tumorigenic mouse fibrosarcoma at the site of early phase of inflammation caused by plastic plates.

Authors:  F Okada; M Hosokawa; J Hamada; J Hasegawa; M Mizutani; N Takeichi; H Kobayashi
Journal:  Jpn J Cancer Res       Date:  1993-12

3.  Enhancement of tumorigenicity and invasion capacity of rat mammary adenocarcinoma cells by epidermal growth factor and transforming growth factor-beta.

Authors:  X Li; H Nagayasu; J Hamada; M Hosokawa; N Takeichi
Journal:  Jpn J Cancer Res       Date:  1993-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.